Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:92531rdf:typepubmed:Citationlld:pubmed
pubmed-article:92531lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:92531lifeskim:mentionsumls-concept:C0020966lld:lifeskim
pubmed-article:92531lifeskim:mentionsumls-concept:C0014063lld:lifeskim
pubmed-article:92531lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:92531pubmed:issue3lld:pubmed
pubmed-article:92531pubmed:dateCreated1980-2-28lld:pubmed
pubmed-article:92531pubmed:abstractTextCell-mediated immunity (CMI) toward myelin human basic protein (HBP) was studied in 19 chronic drug-free schizophrenic patients and in 30 patients with primary affective disorders receiving psychoactive drugs, 74% of the schizophrenics showed an inhibition of macrophage migration, whereas only one patient from the affective group showed such a response. These results indicate that drugs are not responsible for the appearance of CMI to HBP in schizophrenics. One out of 9 ECT-treated patients developed a CMI to HBP.lld:pubmed
pubmed-article:92531pubmed:languageenglld:pubmed
pubmed-article:92531pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:92531pubmed:citationSubsetIMlld:pubmed
pubmed-article:92531pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:92531pubmed:statusMEDLINElld:pubmed
pubmed-article:92531pubmed:monthAuglld:pubmed
pubmed-article:92531pubmed:issn0022-510Xlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:JoshuaHHlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:LivneAAlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:TyanoSSlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:MunitzHHlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:WysenbeekHHlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:KuritzkyAAlld:pubmed
pubmed-article:92531pubmed:authorpubmed-author:EnglanderTTlld:pubmed
pubmed-article:92531pubmed:issnTypePrintlld:pubmed
pubmed-article:92531pubmed:volume42lld:pubmed
pubmed-article:92531pubmed:ownerNLMlld:pubmed
pubmed-article:92531pubmed:authorsCompleteYlld:pubmed
pubmed-article:92531pubmed:pagination437-40lld:pubmed
pubmed-article:92531pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Hu...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Sc...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Ag...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Fe...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-El...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Ma...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Ad...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Mi...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Au...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-Im...lld:pubmed
pubmed-article:92531pubmed:meshHeadingpubmed-meshheading:92531-My...lld:pubmed
pubmed-article:92531pubmed:year1979lld:pubmed
pubmed-article:92531pubmed:articleTitleFurther studies on cell-mediated immunity to myelin basic protein in schizophrenic patients.lld:pubmed
pubmed-article:92531pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:92531lld:pubmed